Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TMIGD3 | P0DMS9 | 5/20 | 0.34 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | RAB9A | P51151 | 4/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SHMT2 | P34897 | 1/20 | 0.31 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.31 |
| ▸ | PARP1 | P09874 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10085120 | 0.72 | — | — | |
| SCHEMBL15281526 | 0.68 | GSK3B (0.33) | — | |
| SCHEMBL793207 | 0.67 | ABCB11 (0.37) | HPGDALDH1A1SMN1; SMN2MAPTLMNA | |
| SCHEMBL793629 | 0.64 | NQO2 (0.36) | MAPTKDM4E | |
| SCHEMBL30488643 | 0.64 | — | — | |
| SCHEMBL14691351 | 0.63 | USP8 (0.30) | — | |
| SCHEMBL15277875 | 0.63 | PDPK1 (0.34) | TMIGD3ADORA1ALDH1A1PDPK1 | |
| SCHEMBL11325702 | 0.61 | SRC (0.46) | CYP1A2HPGDALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL342450 | 0.61 | SRC (0.46) | CYP1A2HPGDALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL19352840 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9716241-B2 | Polycyclic dithiophenes | BASF SE (DE) | 2017-07-25 | — | — | US | disclosed |
| US-20160104849-A1 | POLYCYCLIC DITHIOPHENES | BASF SE (DE) | 2016-04-14 | — | — | US | disclosed |
| US-9233930-B2 | Polycyclic dithiophenes | BASF SE (DE) | 2016-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160104849-A1 | POLYCYCLIC DITHIOPHENES | C1R, C2CD5, CBR3 | TMIGD3 3243/4885ADORA1 2558/4885CYP1A2 3622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.